Evolus (EOLS) Depreciation & Amortization (CF) (2017 - 2026)
Evolus' (EOLS) quarterly Depreciation & Amortization (CF) came in at $2.3 million in Q1 2026, up 50.1% YoY from $1.6 million in Q1 2025, and up 4.08% on a QoQ basis from $2.3 million in Q4 2025.
Evolus (EOLS) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 50.1% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 52.06% YoY) and the FY2025 annual result came in at $7.5 million, up 41.7% from the prior year.
- Depreciation & Amortization (CF) grew to $2.3 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.3 million in Q1 2026 to a low of $853000.0 in Q2 2022.
- A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) tumbled 54.65% — and 2025, when it jumped 79.48%.
- Tracing EOLS's Depreciation & Amortization (CF) over 5 years: stood at $1.0 million in 2022, then jumped by 33.69% to $1.4 million in 2023, then increased by 0.07% to $1.4 million in 2024, then soared by 64.05% to $2.3 million in 2025, then advanced by 4.08% to $2.3 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evolus | 550.51 Mn | 505.34 Mn | 57.18 Mn | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.34 Mn |
| Jun 30, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.35 Mn |
| Mar 31, 2026 | 2.35 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.41 Mn |